Stock listing
Lang & Schwarz:A2PKLC Armata Pharmaceuticals, Inc. Aktie
German listing (Lang & Schwarz) of Armata Pharmaceuticals, Inc. · home listing NYSE American:ARMP
Follow Armata Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · AMEX:ARMP
$3.07 USD -0.30 (-8.9%)
Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, AMEX:ARMP
- Day range
- $3.07 – $3.41 USDOct 19, 2026
- Volume
- 88,254 sharesOct 19, 2026
- Market cap
- $114.1M USDAt the close on Oct 19, 2026 · price × 37.18M shares outstanding

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:ARMP · Home | $3.07 USD | -0.30 (-8.9%) | 88,254 | $3.33 | $3.41 | $3.07 | $3.37 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · AMEX:ARMP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.07 | -0.30 | -8.9% | $3.33 | $3.41 | $3.07 | 88,254 | |
| $3.37 | +0.28 | +9.1% | $3.08 | $3.42 | $3.006 | 154,311 | |
| $3.09 | +0.31 | +11.2% | $2.86 | $3.155 | $2.845 | 115,670 | |
| $2.78 | -0.32 | -10.3% | $3.06 | $3.06 | $2.745 | 125,536 | |
| $3.10 | -0.53 | -14.6% | $3.68 | $3.68 | $3.01 | 223,187 | |
| $3.63 | 0.00 | 0.0% | $3.65 | $3.84 | $3.56 | 45,900 | |
| $3.63 | -0.23 | -6.0% | $3.90 | $3.95 | $3.62 | 100,600 | |
| $3.86 | +0.05 | +1.3% | $3.79 | $3.91 | $3.59 | 70,300 | |
| $3.81 | -0.04 | -1.0% | $3.83 | $4.07 | $3.72 | 103,600 | |
| $3.85 | +0.19 | +5.2% | $3.69 | $3.93 | $3.66 | 114,600 | |
| $3.66 | +0.14 | +4.0% | $3.54 | $3.68 | $3.51 | 56,600 | |
| $3.52 | +0.21 | +6.3% | $3.40 | $3.55 | $3.32 | 124,500 | |
| $3.31 | -0.36 | -9.8% | $3.67 | $3.78 | $3.28 | 76,400 | |
| $3.67 | +0.08 | +2.2% | $3.57 | $3.74 | $3.53 | 127,000 | |
| $3.59 | -0.19 | -5.0% | $3.74 | $3.74 | $3.52 | 91,800 | |
| $3.78 | +0.04 | +1.1% | $3.66 | $3.85 | $3.55 | 85,700 | |
| $3.74 | +0.12 | +3.3% | $3.60 | $3.81 | $3.56 | 100,800 | |
| $3.62 | -0.02 | -0.5% | $3.70 | $3.83 | $3.53 | 144,400 | |
| $3.64 | -0.56 | -13.3% | $4.20 | $4.30 | $3.60 | 286,900 | |
| $4.20 | -0.06 | -1.4% | $4.27 | $4.56 | $4.14 | 128,300 | |
| $4.26 | +0.08 | +1.9% | $4.24 | $4.36 | $4.10 | 82,900 | |
| $4.18 | +0.08 | +2.0% | $4.07 | $4.40 | $4.00 | 160,600 | |
| $4.10 | +0.03 | +0.7% | $4.32 | $4.32 | $4.09 | 253,300 | |
| $4.07 | -0.33 | -7.5% | $4.40 | $4.44 | $3.99 | 307,100 | |
| $4.40 | -1.15 | -20.7% | $5.24 | $5.35 | $4.23 | 646,200 | |
| $5.55 | +0.17 | +3.2% | $6.17 | $6.64 | $4.73 | 4,743,600 | |
| $5.38 | +0.15 | +2.9% | $5.30 | $5.55 | $5.26 | 43,600 | |
| $5.23 | -0.18 | -3.3% | $5.39 | $5.74 | $5.12 | 115,400 | |
| $5.41 | -0.41 | -7.0% | $5.76 | $5.79 | $5.40 | 17,900 | |
| $5.82 | -0.02 | -0.3% | $5.76 | $5.88 | $5.59 | 47,400 | |
| $5.84 | +0.32 | +5.8% | $5.49 | $5.87 | $5.48 | 48,000 | |
| $5.52 | -0.01 | -0.2% | $5.53 | $5.62 | $5.20 | 49,300 | |
| $5.53 | +0.25 | +4.7% | $5.36 | $5.62 | $5.27 | 70,100 | |
| $5.28 | -0.23 | -4.2% | $5.51 | $5.68 | $5.19 | 46,500 | |
| $5.51 | +0.14 | +2.6% | $5.35 | $5.52 | $5.18 | 51,500 | |
| $5.37 | -0.06 | -1.1% | $5.37 | $5.45 | $4.99 | 49,700 | |
| $5.43 | -0.02 | -0.4% | $5.42 | $5.47 | $4.73 | 270,500 | |
| $5.45 | -0.11 | -2.0% | $5.59 | $5.59 | $5.30 | 62,200 | |
| $5.56 | +0.39 | +7.5% | $5.23 | $5.70 | $5.23 | 94,290 | |
| $5.17 | +0.07 | +1.4% | $5.10 | $5.26 | $4.862 | 67,744 | |
| $5.10 | +0.68 | +15.4% | $4.42 | $5.10 | $4.42 | 111,500 | |
| $4.42 | -0.65 | -12.8% | $4.98 | $5.17 | $4.12 | 222,100 | |
| $5.07 | +0.51 | +11.2% | $4.61 | $5.10 | $4.61 | 104,700 | |
| $4.56 | +0.08 | +1.8% | $4.44 | $4.67 | $4.44 | 36,000 | |
| $4.48 | -0.08 | -1.8% | $4.54 | $4.65 | $4.27 | 51,100 | |
| $4.56 | -0.26 | -5.4% | $4.79 | $4.93 | $4.40 | 110,600 | |
| $4.82 | +0.51 | +11.8% | $4.32 | $5.04 | $4.32 | 169,000 | |
| $4.31 | +0.06 | +1.4% | $4.26 | $4.42 | $3.96 | 126,500 | |
| $4.25 | -0.35 | -7.6% | $4.60 | $4.86 | $4.14 | 231,100 | |
| $4.60 | -0.11 | -2.3% | $4.92 | $4.92 | $4.52 | 81,600 | |
| $4.71 | +0.01 | +0.2% | $4.70 | $4.88 | $4.62 | 37,500 | |
| $4.70 | 0.00 | 0.0% | $4.67 | $4.78 | $4.60 | 103,900 | |
| $4.70 | +0.02 | +0.4% | $4.69 | $4.75 | $4.51 | 103,800 | |
| $4.68 | -0.37 | -7.3% | $5.09 | $5.695 | $4.64 | 276,234 | |
| $5.05 | +0.51 | +11.2% | $4.54 | $5.14 | $4.54 | 60,161 | |
| $4.54 | -0.24 | -5.0% | $4.76 | $4.84 | $4.52 | 30,800 | |
| $4.78 | +0.21 | +4.6% | $4.62 | $4.99 | $4.45 | 64,100 | |
| $4.57 | -0.16 | -3.4% | $4.70 | $4.96 | $4.56 | 97,500 | |
| $4.73 | -0.42 | -8.2% | $5.15 | $5.15 | $4.605 | 59,324 | |
| $5.15 | +0.49 | +10.5% | $4.66 | $5.215 | $4.36 | 96,036 | |
| $4.66 | -0.56 | -10.7% | $5.28 | $5.29 | $4.65 | 63,400 | |
| $5.22 | -0.02 | -0.4% | $5.19 | $5.50 | $5.17 | 102,200 | |
| $5.24 | +0.08 | +1.6% | $5.09 | $5.35 | $4.88 | 127,600 | |
| $5.16 | +0.10 | +2.0% | $4.86 | $5.25 | $4.62 | 270,000 | |
| $5.06 | +0.55 | +12.2% | $4.58 | $5.40 | $4.58 | 537,800 |
- Ticker
- Lang & Schwarz:A2PKLC
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Sep 23, 2026
Armata Pharmaceuticals Receives $3.7 Million in Additional Non-Dilutive Funding from U.S. Department of War to Support Advancement of AP-SA02 Phase 3 Development
Latest deck · Sep 14, 2026
Investor Presentation (September 2026)
Investor deck · 52 slides
Latest news
Armata Pharmaceuticals Receives $3.7 Million in Additional Non-Dilutive Funding from U.S. Department of War to Support Advancement of AP-SA02 Phase 3 Development
Sep 23, 2026
Closed $3.64 (-13.3%) on Sep 23, 2026
Armata Pharmaceuticals to Present Data at ISSSI 2026 Showing Defined Genetic Diversity in AP-SA02 May Enhance Killing of Certain Staphylococcus aureus Clinical Isolates
Sep 21, 2026
Closed $4.26 (+1.9%) on Sep 21, 2026
Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02
Sep 14, 2026
Closed $5.55 (+3.2%) on Sep 14, 2026
Armata Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep 10, 2026
Closed $5.23 (-3.3%) on Sep 10, 2026
Armata Pharmaceuticals Announces New Publication That Advances Understanding of Phage Biology to Support Development of Next-Generation Antibacterials
Sep 3, 2026
Closed $5.52 (-0.2%) on Sep 3, 2026
Armata Pharmaceuticals Announces Financial Results for the Second Quarter 2026 and Provides a Corporate Update
Aug 12, 2026
Closed $4.82 (+11.8%) on Aug 13, 2026
Armata Pharmaceuticals Achieves Key Progress Across Clinical, Regulatory and Manufacturing Activities Supporting Planned Phase 3 Initiation of AP-SA02
Jul 20, 2026
Closed $5.06 (+12.2%) on Jul 20, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 52 slides · Sep 14, 2026
IDWeek 2025
Conference · 16 slides · Oct 22, 2025
H.C. Wainwright 27th Annual Global Investment Conference (September 2025)
Conference · 29 slides · Sep 11, 2025
Investor Presentation (May 2025)
Investor deck · 39 slides · May 19, 2025
Armata Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 22 in the last 12 months · 36 in all · newest Sep 23, 2026 · oldest 2024
- Decks
- 23 decks · latest Sep 14, 2026
Where Armata Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:ARMP · Home listing | NYSE American | United States | USD |
| gettex:TG1N | gettex | Germany | EUR |
| Lang & Schwarz:A2PKLC · This page | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2PKLC | LS Exchange | Germany | EUR |
| BOATS:ARMP | BOATS | United States | USD |
| Tradegate:TG1N | Tradegate | Germany | EUR |
| Dusseldorf:TG1N | Dusseldorf | Germany | EUR |
| Frankfurt:TG1N | Frankfurt | Germany | EUR |
| Munich:TG1N | Munich | Germany | EUR |
| Stuttgart:TG1N | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Armata Pharmaceuticals, Inc.